| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |